77
Views
5
CrossRef citations to date
0
Altmetric
Original Research

RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses

, &
Pages 3357-3369 | Published online: 10 Sep 2018

References

  • BucheggerKIliCRiquelmeIReprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell lineBiol Res201649526796959
  • BaiLZhuWGp53 structure, function and therapeutic applicationsJ Cancer Mol200624141153
  • HauptSBuckleyDPangJ-MBTargeting Mdmx to treat breast cancers with wild-type p53Cell Death Dis201667e1821
  • YuanCHFilippovaMKrstenanskyJLDuerksen-HughesPJFla-vonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV(+) cellsCell Death Dis20167206026794656
  • PughDJAbEFaroALutyaPTHoffmannEReesDJDWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathwaysBMC Struct Biol20066116396680
  • MoelaPChoeneMSMotadiLRSilencing RBBP6 (retinoblastoma binding protein 6) sensitises breast cancer cells MCF-7 to staurosporine and camptothecin-induced cell deathImmunobiology2014219513601
  • GartelALFelicianoCTynerALA new method for determining the status of p53 in tumour cell lines of different originOncol Res2003136–1040540812725531
  • AagaardLRossiJJRNAi therapeutics: principles, prospects and challengesAdv Drug Deliv Rev200759758617449137
  • MeisterGTuschlTMechanisms of gene silencing by double-stranded RNANature200443134334915372041
  • MiottoBChibiMXiePThe RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile site stabilityCell Rep20147257558724726359
  • LiLDengBXingGPACT is a negative regulator of p53 and essential for cell growth and embryonic developmentProc Natl Acad Sci U S A2007104197951795617470788
  • MotadiLRMissoNLDlaminiZBhoolaKDMolecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targetsInt Immunopharmacol200771934194718039530
  • LiuJJLinMYuJYLiuBBaoJKTargeting apoptotic and autophagic pathways for cancer therapeuticsCancer Lett2011300210511421036469
  • WenXLinZQLiuBWeiYQCaspase-mediated programmed cell death pathways as potential therapeutic targets in cancerCell Prolif20124521722422429822
  • OuyangLShiZZhaoSProgrammed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosisCell Prolif20124548749823030059
  • GergelyPGrossmanCNilandBMitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosusArthritis Rheum200246117519011817589
  • EguchiYShimizuSTsujimotoYIntracellular ATP levels determine cell death fate by apoptosis or necrosisCancer Res199757183518409157970
  • RichterCSchweizerMCossarizzaAFranceschiCControl of apoptosis by the cellular ATP levelFEBS Lett19963781071108549813
  • Chazin EdeLReis RdaRJuniorWTMoorLFVasconcelosTRAn overview on the development of new potentially active camptothecin analogs against cancerMini Rev Med Chem2014141295396225355593
  • McCartyMFA role for cAMP-driven transactivation of EGFR in cancer aggressiveness - therapeutic implicationsMed Hypotheses201483214214724932579
  • TakeharaAHosokawaMEguchiHGamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor P subunitCancer Res200767209704971217942900
  • CarettaAMucignat-CarettaCProtein kinase A in cancerCancers (Basel)2011391392624212646
  • KümlerIBrünnerNStenvangJBalslevENielsenDLA systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancerBreast Cancer Res Treat2013138234735823512247
  • HsiangYHHertzbergRHechtSLiuLFCamptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase IJ Biol Chem19852602714873148782997227
  • KhodjakovARiederCLThe nature of cell-cycle checkpoints: facts and fallaciesJ Biol20098108819930621
  • OhCHOhSHEffects of germinated brown rice extracts with enhanced levels of GABA on cancer cell proliferation and apoptosisJ Med Food200471192315117548
  • SchullerHMAl-WadeiHANMajidiMThe GABAB receptor is a novel drug target for pancreatic cancerCancer2008112476777818098271
  • HuiLZhengYYanYBargonettiJFosterDAMutant p53 in MDAMB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase DOncogene2006257305731016785993
  • HuiLAbbasTPielakRMJosephTBargonettiJFosterDAPhospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53Mol Cell Biol200424135677568615199126
  • TaoZShiALuCSongTZhangZZhaoJBreast cancer: epidemiology and etiologyCell Biochem Biophys20157233333825543329